Abstract
Metrifonate concentrations in plasma, its inhibition of blood cholinesterase, and side-effects were studied in 16 healthy volunteers who received a single oral dose of 2.5, 5, 7.5 or 15 mg/kg in a randomized double-blind study (4 subjects for each dose). Metrifonate was determined by a gas chromatographic method. Peak plasma levels were reached within 2 hours; the half-life in plasma, oral clearance, and normalized Cmax and AUCs did not differ significantly between the four groups. Plasma cholinesterase (BuchE) was inhibited to low levels in all subjects, while erythrocyte cholinesterase (AchE) was affected in a dose-dependent fashion. The occurrence of side-effects correlated strongly with peak plasma levels but not with maximum AchE inhibition or with increase in salivation. This study shows that the absorption of metrifonate was not significantly different for doses between 2.5 and 15 mg/kg. The plasma levels of this drug correlated with the occurrence of side-effects.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aden Abdi Y., Gustafsson L. L. Field trial of the efficacy of a simplified and standard metrifonate treatments of Schistosoma haematobium. Eur J Clin Pharmacol. 1989;37(4):371–374. doi: 10.1007/BF00558502. [DOI] [PubMed] [Google Scholar]
- Aden-Abdi Y., Gustafsson L. L., Elmi S. A. A simplified dosage schedule of metrifonate in the treatment of Schistosoma haematobium infection in Somalia. Eur J Clin Pharmacol. 1987;32(5):437–441. doi: 10.1007/BF00637666. [DOI] [PubMed] [Google Scholar]
- Augustinsson K. B., Eriksson H., Faijersson Y. A new approach to determining cholinesterase activities in samples of whole blood. Clin Chim Acta. 1978 Oct 16;89(2):239–252. doi: 10.1016/0009-8981(78)90322-4. [DOI] [PubMed] [Google Scholar]
- Nordgren I., Holmstedt B., Bengtsson E., Finkel Y. Plasma levels of metrifonate and dichlorvos during treatment of schistosomiasis with bilarcil. Am J Trop Med Hyg. 1980 May;29(3):426–430. doi: 10.4269/ajtmh.1980.29.426. [DOI] [PubMed] [Google Scholar]
- Nordin C., Bertilsson L., Otani K., Widmark A. Little anticholinergic effect of E-10-hydroxynortriptyline compared with nortriptyline in healthy subjects. Clin Pharmacol Ther. 1987 Jan;41(1):97–102. doi: 10.1038/clpt.1987.16. [DOI] [PubMed] [Google Scholar]
- PECK R. E. The SHP test--an aid in the detection and measurement of depression. AMA Arch Gen Psychiatry. 1959 Jul;1:35–40. doi: 10.1001/archpsyc.1959.03590010051006. [DOI] [PubMed] [Google Scholar]
- Steiner E., Bertilsson L., Säwe J., Bertling I., Sjöqvist F. Polymorphic debrisoquin hydroxylation in 757 Swedish subjects. Clin Pharmacol Ther. 1988 Oct;44(4):431–435. doi: 10.1038/clpt.1988.176. [DOI] [PubMed] [Google Scholar]